IMMUNOME INC. (IMNM)
Clinical trial NCT04871282 updates: 1. start date: 2021-03-30 → 2021-09-01 2. completion date: 2026-10-01 → 2026-12-01 3. masking: TRIPLE → QUADRUPLE
Clinical trial NCT04871282 updates: 1. start date: 2021-03-30 → 2021-09-01 2. completion date: 2026-10-01 → 2026-12-01 3. masking: TRIPLE → QUADRUPLE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical